NDAQ vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 13, 2026

NDAQ

60.1
AI Score
VS
NDAQ Wins

CME

58.9
AI Score

Investment Advisor Scores

NDAQ

60score
Recommendation
BUY

CME

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NDAQ CME Winner
Forward P/E 24.6914 22.9885 CME
PEG Ratio 2.3082 4.7612 NDAQ
Revenue Growth 13.7% 14.4% CME
Earnings Growth 33.8% 21.3% NDAQ
Tradestie Score 60.1/100 58.9/100 NDAQ
Profit Margin 35.3% 63.3% CME
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD NDAQ

Frequently Asked Questions

Based on our detailed analysis, NDAQ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.